{
    "code": "02020248",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020248",
    "time": "2019-04-26 03:50:26",
    "許可證字號": "衛署藥輸字第020248號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/01\/04",
    "發證日期": "83\/01\/04",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202024802",
    "中文品名": "鹽酸服拉沃塞",
    "英文品名": "FLAVOXATE HYDROCHLORIDE",
    "適應症": "肌肉鬆弛劑。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "主成分略述": [
        "FLAVOXATEHCL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620109C968  新雙隆生技股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260467000  DAITO PHARMACEUTICAL CO., LTD.",
        "製造廠廠址": "326,YOKAMACHI, TOYAMA-CITY, TOYAMA 939-8221, JAPAN",
        "製造廠公司地址": ""
    },
    "CCC號列": "29333990905 其他結構中含有一未稠合之?啶環（不論是否氫化）之化合物Other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002310",
            "成分名稱": "FLAVOXATE HCL",
            "含量描述": "99.0",
            "含量": "99.0000000000",
            "單位": "%"
        }
    ]
}